Schering-Plough
SGP
#545
Rank
โ‚ฌ39.24 B
Marketcap
N/A
Share price
0.00%
Change (1 day)
N/A
Change (1 year)
Schering-Plough was a major American pharmaceutical company that developed and marketed a range of prescription drugs. In 2009, Schering-Plough was acquired by Merck & Co. in a $41 billion USD deal.

Schering-Plough (SGP) - Total debt

Total debt on the balance sheet as of December 2008 : โ‚ฌ6.94 Billion

According to Schering-Plough's latest financial reports the company's total debt is โ‚ฌ6.94 Billion. A companyโ€™s total debt is the sum of all current and non-current debts.

Schering-Plough - Total debt on balance sheet (from 1996 to 2008)

Total debt by year

Year Total debt Change
2008-12-31โ‚ฌ5.84 B
2006-12-31โ‚ฌ2.01 B-35.15%
2005-12-31โ‚ฌ3.10 B6.3%
2004-12-31โ‚ฌ2.92 B7.09%
2003-12-31โ‚ฌ2.72 B-33.91%
2002-12-31โ‚ฌ4.12 B91.78%
2001-12-31โ‚ฌ2.15 B-22.94%
2000-12-31โ‚ฌ2.79 B
1998-12-31โ‚ฌ1.72 B-16.42%
1997-12-31โ‚ฌ2.06 B120.95%
1996-12-31โ‚ฌ0.93 B